{{copyedit|time=2019-10-08T17:26:15+00:00}}
{{infobox protein
| Name = [[缺氧誘導因子-1,α亞基|缺氧誘導因子-1,α亞基]] (hypoxia-inducible factor 1, alpha subunit)
| caption = 
| image = 
| width = 
| HGNCid = 4910
| Symbol = [[HIF1A|HIF1A]]
| AltSymbols = 
| EntrezGene = 3091
| OMIM = 603348
| RefSeq = NM_001530
| UniProt = Q16665
| PDB = 
| ECnumber = 
| Chromosome = 14
| Arm = q
| Band = 21
| LocusSupplementaryData = -q24
}}
{{infobox protein
| Name = [[芳香烴受體核轉|芳香烴受體核轉]] (aryl hydrocarbon receptor nuclear translocator)
| caption =
| image =
| width =
| HGNCid = 700
| Symbol = [[aryl_hydrocarbon_receptor_nuclear_translocator|ARNT]]
| AltSymbols = HIF1B, bHLHe2
| EntrezGene = 405
| OMIM =  126110
| RefSeq =  NM_001668
| UniProt =  P27540
| PDB =
| ECnumber =
| Chromosome = 1
| Arm = q
| Band = 21
| LocusSupplementaryData =
}}
{{infobox protein
| Name = [[内皮PAS域蛋白-1|内皮PAS域蛋白-1]] (endothelial PAS domain protein 1)
| caption =
| image =
| width =
| HGNCid = 3374
| Symbol = [[EPAS1|EPAS1]]
| AltSymbols = HIF2A, MOP2, PASD2, HLF
| EntrezGene = 2034
| OMIM = 603349
| RefSeq = NM_001430
| UniProt = Q99814
| PDB =
| ECnumber =
| Chromosome = 2
| Arm = p
| Band = 21
| LocusSupplementaryData = -p16
}}
{{infobox protein
| Name = [[芳香烴受體核轉-2|芳香烴受體核轉-2]] (aryl-hydrocarbon receptor nuclear translocator 2)
| caption =
| image =
| width =
| HGNCid = 16876
| Symbol = [[ARNT2|ARNT2]]
| AltSymbols = HIF2B, KIAA0307, bHLHe1
| EntrezGene = 9915
| OMIM = 606036
| RefSeq = NM_014862
| UniProt = Q9HBZ2
| PDB =
| ECnumber =
| Chromosome = 1
| Arm = q
| Band = 24
| LocusSupplementaryData =
}}
{{infobox protein
| Name = [[缺氧誘導因子-3,α亞基|缺氧誘導因子-3,α亞基]](hypoxia-inducible factor 3, alpha subunit)
| caption = 
| image = 
| width = 
| HGNCid = 15825
| Symbol = [[HIF3A|HIF3A]]
| AltSymbols = 
| EntrezGene = 64344
| OMIM = 609976
| RefSeq = NM_152794
| UniProt = Q9Y2N7
| PDB = 
| ECnumber = 
| Chromosome = 19
| Arm = q
| Band = 13
| LocusSupplementaryData = 
}}

'''缺氧誘導因子'''（Hypoxia-inducible factors，HIFs）是一種在細胞環境中的[[轉錄因子|轉錄因子]]，因氧含量而產生不同反應的，主要是在氧氣減少或[[缺氧|缺氧]]<ref name="pmid18410568">{{cite journal | author = Smith TG, Robbins PA, Ratcliffe PJ | title = The human side of hypoxia-inducible factor | journal = Br. J. Haematol. | volume = 141 | issue = 3 | pages = 325–34 |date=May 2008 | pmid = 18410568 | pmc = 2408651 | doi = 10.1111/j.1365-2141.2008.07029.x | url =   }}</ref>
的情況下活化。
== 結構 ==
缺氧大部分需要氧氣呼吸的物種，都擁有[[保守序列|保守序列]]HIF-1。其轉錄都有嚴格的調控機制。HIF-1是由一個α亞基和一個β亞基組成的異源[[蛋白二聚體|蛋白二聚體]]，而β亞基是一種{{le|芳香烃受体核转位子|Aryl hydrocarbon receptor nuclear translocator}}（ARNT） <ref name="pmid7539918">{{cite journal | author = Wang GL, Jiang BH, Rue EA, Semenza GL | title = Hypoxia-inducible factor 1 is a basic helix-loop-helix-PAS heterodimer regulated by cellular O2 tension | journal = Proc. Natl. Acad. Sci. U.S.A. | volume = 92 | issue = 12 | pages = 5510–4 |date=June 1995 | pmid = 7539918 | pmc = 41725 | doi = 10.1073/pnas.92.12.5510| url = }}</ref><ref name="pmid8663540">{{cite journal | author = Jiang BH, Rue E, Wang GL, Roe R, Semenza GL | title = Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1 | journal = J. Biol. Chem. | volume = 271 | issue = 30 | pages = 17771–8 |date=July 1996 | pmid = 8663540 | doi = 10.1074/jbc.271.30.17771| url =  }}</ref>。 HIF-1屬於[[鹼性螺旋-環-螺旋|鹼性螺旋-環-螺旋]]（bHLH）家族中的[[PER-ARNT-SIM|PER-ARNT-SIM]]（PAS）亞科。 α亞基和β亞基的結構類似，且都包含下列結構域<ref name="pmid9301332">{{cite journal | author = Zhulin IB, Taylor BL, Dixon R | title = PAS domain S-boxes in Archaea, Bacteria and sensors for oxygen and redox | journal = Trends Biochem. Sci. | volume = 22 | issue = 9 | pages = 331–3 |date=September 1997 | pmid = 9301332 | doi = 10.1016/S0968-0004(97)01110-9| url =  }}</ref><ref name="pmid9382818">{{cite journal | author = Ponting CP, Aravind L | title = PAS: a multifunctional domain family comes to light | journal = Curr. Biol. | volume = 7 | issue = 11 | pages = R674–7 |date=November 1997 | pmid = 9382818 | doi = 10.1016/S0960-9822(06)00352-6| url =  }}</ref><ref name="pmid16129688">{{cite journal | author = Yang J, Zhang L, Erbel PJ, Gardner KH, Ding K, Garcia JA, Bruick RK | title = Functions of the Per/ARNT/Sim domains of the hypoxia-inducible factor | journal = J. Biol. Chem. | volume = 280 | issue = 43 | pages = 36047–54 |date=October 2005 | pmid = 16129688 | doi = 10.1074/jbc.M501755200 | url =  }}</ref>：

*  [[N-末端|N-末端]] - 一個bHLH結構域，能和DNA結合。
*  中間區域 - [[Per-ARNT-Sim|Per-ARNT-Sim]] (PAS)結構域，有利於形成異源[[蛋白二聚體|蛋白二聚體]]。
*  [[C-末端|C-末端]] - 一個能與{{le|转录辅调节因子|Transcription coregulator}}結合的蛋白質，促使[[轉錄共調節|轉錄共調節]]。
{|
|- valign=top
|{{Infobox protein family
| Symbol = HIF-1
| Name = 缺氧誘導因子-1
| image = PDB 1lm8 EBI.jpg
| width = 
| caption = HIF-1a-pVHL-ElonginB-ElonginC 複合體 的結構之一。<ref name="pmid12004076">{{cite journal |author=Min JH, Yang H, Ivan M, Gertler F, Kaelin WG, Pavletich NP |title=Structure of an HIF-1alpha -pVHL complex: hydroxyproline recognition in signaling |journal=Science |volume=296 |issue=5574 |pages=1886–9 |date=June 2002 |pmid=12004076 |doi=10.1126/science.1073440 |url=}}</ref>
| Pfam = PF11413
| Pfam_clan = 
| InterPro = 
| SMART = 
| PROSITE = 
| MEROPS =
| SCOP = 
| TCDB = 
| OPM family = 
| OPM protein = 
| PDB = 
}}
|{{Infobox protein family
| Symbol = HIF-1a_CTAD
| Name = HIF-1α的C末端激活域
| image = PDB 1l3e EBI.jpg
| width = 
| caption = 缺氧誘導因子-1,α亞基 的結構之一 .<ref name="pmid11959990">{{cite journal |author=Freedman SJ, Sun ZY, Poy F, ''et al.'' |title=Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1 alpha |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue=8 |pages=5367–72 |date=April 2002 |pmid=11959990 |pmc=122775 |doi=10.1073/pnas.082117899 |url=}}</ref>
| Pfam = PF08778
| Pfam_clan = 
| InterPro = IPR014887
| SMART = 
| PROSITE = 
| MEROPS =
| SCOP = 1l3e
| TCDB = 
| OPM family = 
| OPM protein = 
| PDB = {{PDB2|1h2k}}, {{PDB2|1h2l}}, {{PDB2|1l3e}}, {{PDB2|1l8c}} 
}}
|}

== 成員 ==
下列為人類的 HIF 家族:

{| class="wikitable" border="1"
|-
! 成員
! 基因
! 蛋白
|-
| [[HIF1A|HIF-1α]]
| [https://web.archive.org/web/20170828144049/http://www.genenames.org/cgi-bin/gene_symbol_report?q=data%2Fhgnc_data.php&match=HIF1A HIF1A]
| 缺氧誘導因子-1,α亞基
|-
| [[HIF1B|HIF-1β]]
| [https://web.archive.org/web/20160512133940/http://www.genenames.org/cgi-bin/gene_symbol_report?q=data%2Fhgnc_data.php&match=ARNT HIF-1β]
| 芳香烴受體核轉
|-
| [[EPAS1|HIF-2α]]
| [https://web.archive.org/web/20160401050308/http://www.genenames.org/cgi-bin/gene_symbol_report?q=data%2Fhgnc_data.php&match=EPAS1 EPAS1]
| 内皮PAS域蛋白-1
|-
| [[ARNT2|HIF-2β]]
| [https://web.archive.org/web/20170422020343/http://www.genenames.org/cgi-bin/gene_symbol_report?q=data%2Fhgnc_data.php&match=ARNT2 ARNT2]
| 芳基烴受體核轉-2
|-
| [[HIF3A|HIF-3α]]
| [https://web.archive.org/web/20180107120112/https://www.genenames.org/cgi-bin/gene_symbol_report?q=data%2Fhgnc_data.php&match=HIF3A HIF3A]
| 缺氧誘導因子-3,α亞基
|-
| [[ARNTL|HIF-3β]]
| [https://web.archive.org/web/20170823132343/http://www.genenames.org/cgi-bin/gene_symbol_report?q=data%2Fhgnc_data.php&match=ARNTL ARNTL]
| 芳基烴受體核轉-3
|}

== 作用 ==
在細胞中，HIF信號級聯反應會受到缺氧狀態的影響。在缺氧狀態下，通常會讓細胞持續的[[分化|細胞分化]]。然而，缺氧狀態促進了[[血管新生|血管新生]]，對於[[胚胎|胚胎]]中的[[循環系統|血管系統]]與癌症腫瘤來說非常重要。 傷口處的缺氧狀態，也促進了角質細胞的移動與[[上皮組織|上皮組織]]的修護<ref name="Benizri">{{cite journal | author = Benizri E, Ginouvès A, Berra E | title = The magic of the hypoxia-signaling cascade | journal = Cell. Mol. Life Sci. | volume = 65 | issue = 7-8 | pages = 1133–49 |date=April 2008 | pmid = 18202826 | doi = 10.1007/s00018-008-7472-0 | url =https://archive.org/details/sim_cellular-and-molecular-life-sciences_2008-04_65_7-8/page/1133| issn = }}</ref>。

在普遍情況下，HIF是發育的重要關鍵。在哺乳動物中，若缺少了HIF-1的基因，將導致胎兒死亡。HIF-1已經被證實，對於[[軟骨細胞|軟骨細胞]]的存亡有重大的影響，他能使[[軟骨細胞|軟骨細胞]]適應在[[骨骼|骨骼]]間[[生長板|生長板]]的缺氧環境。缺氧誘導因子在人類的[[代謝|代謝]]調節<ref name="Formenti">{{cite journal | author = Formenti F, Constantin-Teodosiu D, Emmanuel Y, Cheeseman J, Dorrington KL, Edwards LM, Humphreys SM, Lappin TR, McMullin MF, McNamara CJ, Mills W, Murphy JA, O'Connor DF, Percy MJ, Ratcliffe PJ, Smith TG, Treacy M, Frayn KN, Greenhaff PL, Karpe F, Clarke K, Robbins PA | title = Regulation of human metabolism by hypoxia-inducible factor | journal = Proc. Natl. Acad. Sci. U.S.A. | volume = 107 | issue = 28 | pages = 12722–7 |date=July 2010 | pmid = 20616028 | pmc = 2906567 | doi = 10.1073/pnas.1002339107 | url = | issn = }}</ref>中，屬於一個核心角色。

== 機制 ==
HIF中α亞基上的脯氨酸殘會透過[[缺氧誘導因子基脯氨酰羥化酶|HIF脯氨酰羥化酶]]羥基化，而使其能被 VHL E3[[泛素連接酶|泛素連接酶]]辨識並[[泛素化|泛素化]]，之後透過[[蛋白酶體|蛋白酶體]]<ref name="pmid10353251">{{cite journal | author = Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, Ratcliffe PJ | title = The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis | journal = Nature | volume = 399 | issue = 6733 | pages = 271–5 |date=May 1999 | pmid = 10353251 | doi = 10.1038/20459 }}</ref>使其被快速降解。這只會發生在含氧量正常的條件。但在缺氧條件下，[[缺氧誘導因子基脯氨酰羥化酶|HIF脯氨酰羥化酶]]會被抑制，因為它利用氧作為輔助基質<ref name="pmid15304631">{{cite journal | author = Semenza GL | title = Hydroxylation of HIF-1: oxygen sensing at the molecular level | journal = Physiology (Bethesda) | volume = 19 | issue = 4| pages = 176–82 |date=August 2004 | pmid = 15304631 | doi = 10.1152/physiol.00001.2004  }}</ref>。

在[[琥珀酸去氫酶|琥珀酸去氫酶]]複合物中，電子轉移的抑制是因為[[SDHB|SDHB]]或[[SDHD|SDHD]]基因的突變，其會導致琥珀的積聚，進而抑制[[缺氧誘導因子基脯氨酰羥化酶|HIF脯氨酰羥化酶]]的活性，穩定HIF-1,α，這被稱為[[偽組織缺氧|偽組織缺氧]]。

HIF-1，當持續在缺氧條件下，正向調節多種基因以能再低含氧量的情況下生存。 HIF-1能調節的酵素包括[[糖解|糖解作用]]酶，使其能以不耗氧的方式合成[[三磷酸腺苷|三磷酸腺苷]]；還有[[血管內皮生長因子|血管內皮生長因子]]（VEGF），能促進[[血管生成|血管新生]]。HIF-1的觸發，是藉由[[HIF-反應元件|HIF-反應元件]]（HREs）結合到了[[啟動子|啟動子]]上的NCGTG序列。


已有實驗證明，肌A激酶錨定蛋白（mAKAP）組成的E3[[泛素連接酶|泛素連接酶]]能作用於HIF-1，影響其穩定性與定位，使其移動至細胞核中。 當 mAKAP 耗盡或因其他因素干擾 mAKAP 定位在細胞核(心肌細胞)周圍區域時，會影響了HIF的穩定性，與其他和缺氧相關基因的轉錄活性。因此，將對氧氣敏感的信號物件“區域化”，可能影響缺氧時反應的進行。<ref name="pmid19109240">{{cite journal | author = Wong W, Goehring AS, Kapiloff MS, Langeberg LK, Scott JD | title = mAKAP compartmentalizes oxygen-dependent control of HIF-1alpha | journal = Sci Signal | volume = 1 | issue = 51 | pages = ra18 | year = 2008 | pmid = 19109240 | pmc = 2828263 | doi = 10.1126/scisignal.2000026  }}</ref>

在過去，與缺氧環境下HIF的調控機制資訊相較而言，含氧量正常時透過[[NF-κB|NF-κB]]介入的HIF調控機制和功能訊，尚處於不明確的狀況。同樣的，HIF-1α亞基的穩定性，在非缺氧環境下，其運作機制也是未知的。但近期指出，[[核因子活化B細胞κ輕鏈增強子|NF-κB]]（NF-κB）是HIF-1α在正常含氧量下的直接[[調節因子|調節因子]]。以[[小干擾RNA|小干擾RNA]]作用在[[NF-κB|NF-κB]]上發現到，其會影響HIF-1α mRNA 的表現程度，因此證實了NF-κB能HIF-1α的表現。最後，當進行[[腫瘤壞死因子-α|腫瘤壞死因子-α]](TNAα)治療時，[[NF-κB|NF-κB]]被大量誘導表現，HIF-1α表現程度也受到影響<ref name="pmid18393939">{{cite journal | author = van Uden P, Kenneth NS, Rocha S | title = Regulation of hypoxia-inducible factor-1alpha by NF-kappaB | journal = Biochem J. | volume = 412 | issue = 3 | pages = 477–484 | year = 2008 | pmid = 18393939 | doi = 10.1042/BJ20080476 | url = http://www.hif1.com | pmc = 2474706 | access-date = 2022-03-25 | archive-date = 2019-09-02 | archive-url = https://web.archive.org/web/20190902091348/http://hif1.com/ | dead-url = no }}</ref>。HIF-1和HIF-2具有不同的生理作用。HIF-2用於調節成人體內的[[紅血球生成素|紅血球生成素]]。<ref name="pmid20444740">{{cite journal | author = Haase VH | title = Hypoxic regulation of erythropoiesis and iron metabolism | journal = Am. J. Physiol. Renal Physiol. | volume = 299 | issue = 1 | pages = F1–13 |date=July 2010 | pmid = 20444740 | pmc = 2904169 | doi = 10.1152/ajprenal.00174.2010  }}</ref>

== 治療相關 ==

===貧血===
最近，多種作用為選擇性的[[缺氧誘導因子基脯氨酰羥化酶|HIF脯氨酰羥化酶]]的抑制劑已經被開發了。<ref name="pmid17627521">{{cite journal | author = Bruegge K, Jelkmann W, Metzen E | title = Hydroxylation of hypoxia-inducible transcription factors and chemical compounds targeting the HIF-alpha hydroxylases | journal = Curr. Med. Chem. | volume = 14 | issue = 17 | pages = 1853–62 | year = 2007 | pmid = 17627521 | doi = 10.2174/092986707781058850| url =  }}</ref> 其中最引人注目的包括FibroGen公司的化合物FG-2216和FG-4592<ref>[http://www.fibrogen.com/programs/fg-2216/ Dead URL FG-2216: Anemia] {{webarchive|url=https://web.archive.org/web/20080928115535/http://www.fibrogen.com/programs/fg-2216/ |date=2008-09-28 }}</ref><ref>{{cite web |url=http://www.fibrogen.com/Anemia_Clinical_Studies |title=存档副本 |accessdate=2009-05-19 |deadurl=yes |archiveurl=https://web.archive.org/web/20110710235813/http://www.fibrogen.com/Anemia_Clinical_Studies |archivedate=2011-07-10 }}</ref>，是兩個以口服方式治療[貧血]的藥物。<ref name="pmid18301799">{{cite journal | author = Cases A | title = The latest advances in kidney diseases and related disorders | journal = Drug news & perspectives | volume = 20 | issue = 10 | pages = 647–54 |date=December 2007 | pmid = 18301799 | doi = | url = http://journals.prous.com/journals/servlet/xmlxsl/pk_journals.xml_summaryn_pr?p_JournalId=3&p_RefId=3919 | issn =  0214-0934 }}</ref>藉由抑制[[缺氧誘導因子基脯氨酰羥化酶|HIF脯氨酰羥化酶]]，使HIF-2α在腎的穩定性增加，這導致[[紅血球生成素|紅血球生成素]]的生產的<ref name="pmid17557894">{{cite journal | author = Hsieh MM, Linde NS, Wynter A, Metzger M, Wong C, Langsetmo I, Lin A, Smith R, Rodgers GP, Donahue RE, Klaus SJ, Tisdale JF | title = HIF prolyl hydroxylase inhibition results in endogenous erythropoietin induction, erythrocytosis, and modest fetal hemoglobin expression in rhesus macaques | journal = Blood | volume = 110 | issue = 6 | pages = 2140–7 |date=September 2007 | pmid = 17557894 | pmc = 1976368 | doi = 10.1182/blood-2007-02-073254 | url = | issn = }}</ref>。這兩種藥物對II期臨床試驗已經成功了，但這些都在2007年5月暫停了，因為有試驗參發生暴發性[[肝炎|肝炎]]死亡。不過，目前還不清楚[[肝炎|肝炎]]死亡是否是由FG-2216所引起的。在2008年年初，因美國FDA的審查和批准，解除臨床試驗的暫停。 <ref>{{Cite web |url=http://www.astellas.com/en/corporate/news/pdf/080402_eg.pdf |title=The FDA Accepts the Complete Response for Clinical Holds of FG-2216/FG-4592 for the Treatment of Anemia |access-date=2014-06-22 |archive-url=https://web.archive.org/web/20150923175524/http://www.astellas.com/en/corporate/news/pdf/080402_eg.pdf |archive-date=2015-09-23 |dead-url=yes }}</ref>

=== 炎症和癌症  ===
在其它情況中，並接續上面的治療主題。最近的研究表明，在常氧狀態下誘導HIF表現，可能造成含有慢性炎性成分的疾病。且已經表明，慢性[[炎症|炎症]]是自我延續的，並且是因為微環境的異常，而導致[[轉錄因子|轉錄因子]]被異常活化的結果。發生在細胞中，[[生長因子|生長因子]]、[[趨化因子|趨化因子]]、[[細胞因子|細胞因子]]和活性氧平衡的改變，反過提供生長的需要，造成[[癌症|癌症]]發生與轉移。 最近發表的研究結果包含了許多病症，其中有[[NF-κB|NF-κB]]和HIF-1的失調，也有[[類風濕關節炎|類風濕關節炎]]和[[癌症|癌症]]。因此，了解[[NF-κB|NF-κB]]和HIF兩著之間的關係，將大大提高藥物開發的發展。<ref name="pmid18393939"/>

HIF的活性涉及到了[[血管新生|血管新生]]，也造成[[腫瘤|腫瘤]]的生長，所以HIF的抑制劑，如[[異硫氰酸苯乙酯|異硫氰酸苯乙酯]]（Phenethyl isothiocyanate）和[[吖啶黃|吖啶黃]]正在接受抗癌作用的測試。<ref>{{cite journal|pages=17910–17915|title=Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization|volume=106|issue=42|date=2009-10-20|journal=Proceedings of the National Academy of Sciences|url=http://www.pnas.org/cgi/doi/10.1073/pnas.0909353106|accessdate=2018-04-02|author=KangAe Lee, Huafeng Zhang, David Z. Qian, Sergio Rey, Jun O. Liu, Gregg L. Semenza|doi=10.1073/pnas.0909353106}}</ref><ref name="pmid20546646">{{cite journal | author = Syed Alwi SS, Cavell BE, Telang U, Morris ME, Parry BM, Packham G | title = In vivo modulation of 4E binding protein 1 (4E-BP1) phosphorylation by watercress: a pilot study | journal = Br. J. Nutr. | volume = 104 | issue = 9 | pages = 1288–96 |date=November 2010 | pmid = 20546646 | doi = 10.1017/S0007114510002217 | url = | issn = }}</ref><ref name="pmid17933687">{{cite journal | author = Semenza GL | title = Evaluation of HIF-1 inhibitors as anticancer agents | journal = Drug Discov. Today | volume = 12 | issue = 19-20 | pages = 853–9 |date=October 2007 | pmid = 17933687 | doi = 10.1016/j.drudis.2007.08.006 | url = | issn = }}</ref><ref name="pmid16940159">{{cite journal | author = Melillo G | title = Inhibiting hypoxia-inducible factor 1 for cancer therapy | journal = Mol. Cancer Res. | volume = 4 | issue = 9 | pages = 601–5 |date=September 2006 | pmid = 16940159 | doi = 10.1158/1541-7786.MCR-06-0235 | url = | issn = }}</ref>

=== 神經內科 ===
研究指出，在老鼠身上使用[[缺氧誘導因子基脯氨酰羥化酶|HIF脯氨酰羥化酶]]抑制劑，增強[[海馬體|海馬體]]記憶，也增加了[[紅血球生成素|紅血球生成素]]的表現。<ref>{{cite journal|title=Hypoxia inducible factor stabilization leads to lasting improvement of hippocampal memory in healthy mice|pages=80–84|issn=1872-7549|journal=Behavioural Brain Research|volume=208|issue=1|date=2010-03-17|doi=10.1016/j.bbr.2009.11.010|url=https://www.ncbi.nlm.nih.gov/pubmed/19900484|accessdate=2019-02-12|author=Bartosz Adamcio, Swetlana Sperling, Nora Hagemeyer, Gail Walkinshaw, Hannelore Ehrenreich|pmid=19900484|archive-date=2019-07-22|archive-url=https://web.archive.org/web/20190722194408/https://www.ncbi.nlm.nih.gov/pubmed/19900484|dead-url=no}}</ref>

== 另請參閱 ==
* [[HIF1A|HIF-1α]]

== 參考文獻 ==
{{Reflist|2}}

== 外部連結 ==
* {{MeshName|Hypoxia-Inducible+Factor+1}}

{{Transcription factors|g1}}

{{DEFAULTSORT:Hypoxia-Inducible Factors}}
[[分類:發育基因與蛋白質|分類:發育基因與蛋白質]]
[[分類:轉錄因子|分類:轉錄因子]]